Saliva-based microfluidic point-of-care diagnostic
Trey W Pittman1, Daniel Balazs Decsi2,3, Chamindie Punyadeera3,4,5
1Department of Chemistry, Colorado State University, Fort Collins, Colorado 80523, USA.
Theranostics
|February 16, 2023
Summary
Next-generation point-of-care (POC) diagnostics utilize microfluidic devices for non-invasive saliva analysis. This emerging field enhances biomarker detection sensitivity and selectivity for improved patient care.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Clinical Diagnostics
Background:
- Point-of-care (POC) diagnostics offer rapid results but face limitations in invasive sampling and biomarker specificity.
- Existing POC tests like lateral flow assays and glucometers have proven successful but are constrained by device manufacturing and sample requirements.
- Microfluidic devices represent a significant advancement, enabling complex sample processing for more sensitive and selective analysis.
Purpose of the Study:
- To review recent literature on microfluidic devices utilizing saliva for point-of-care diagnostic applications.
- To highlight the advantages of saliva as a non-invasive biofluid for biomarker detection.
- To provide an overview of microfluidic technologies developed for salivary biomarker analysis.
Main Methods:
- Literature review of recent scientific publications focusing on microfluidics and saliva diagnostics.
- Analysis of the characteristics of saliva as a sample matrix for biomarker detection.
- Examination of microfluidic device designs and their application in analyzing salivary biomarkers.
Main Results:
- Saliva is an ideal non-invasive biofluid for POC diagnostics due to its availability and correlation with blood analyte levels.
- Microfluidic devices offer enhanced sample processing capabilities, leading to more sensitive and selective biomarker detection compared to traditional POC methods.
- The field of saliva-based microfluidic diagnostics is rapidly emerging, with ongoing development of novel devices and analytical techniques.
Conclusions:
- Microfluidic devices integrated with saliva analysis hold significant promise for the future of non-invasive point-of-care diagnostics.
- Further research and development in this area can overcome current limitations and expand the clinical utility of salivary biomarkers.
- The transition towards non-invasive sampling methods like saliva analysis in microfluidic POC devices is crucial for improving patient care and accessibility.
